Cowen Inc’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-10,000
Closed -$743K 262
2016
Q3
$791K Hold
10,000
0.05% 156
2016
Q2
$834K Sell
10,000
-16,613
-62% -$1.47M 0.05% 135
2016
Q1
$2.44M Sell
26,613
-159
-0.6% -$14.3K 0.09% 105
2015
Q4
$2.71M Buy
26,772
+5,305
+25% +$552K 0.2% 93
2015
Q3
$2.11M Sell
21,467
-5,328
-20% -$592K 0.13% 104
2015
Q2
$3.14M Sell
26,795
-1,350
-5% -$148K 0.19% 95
2015
Q1
$2.76M Sell
28,145
-14,995
-35% -$1.52M 0.23% 72
2014
Q4
$4.07M Buy
43,140
+2,800
+7% +$290K 0.32% 80
2014
Q3
$4.29M Buy
40,340
+10,010
+33% +$980K 0.44% 60
2014
Q2
$2.52M Buy
30,330
+23,785
+363% +$1.85M 0.28% 95
2014
Q1
$464K Buy
+6,545
New +$513K 0.06% 140

Other funds holding GILD

Cowen Inc's GILD Position: Q4 2016 in Review

Cowen Inc sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 10,000 shares — an estimated $743K sold.

Cowen Inc first reported a position in GILD in Q1 2014 and held it in 11 quarters. The position peaked at $4.29M in Q3 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Cowen Inc reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Cowen Inc sold 10,000 Gilead Sciences shares in Q4 2016, an estimated $743K.
  • Cowen Inc first reported a position in Gilead Sciences in Q1 2014 and held it in 11 quarters.
  • Cowen Inc's Gilead Sciences position peaked at $4.29M in Q3 2014.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Cowen Inc's 13F filing for Q4 2016, filed 13 Feb 2017.